Jingwen Yao • UCLA Profiles (original) (raw)

  1. A multifocal IDH-mutant glioma with differential response to IDH inhibition: Role of quantitative neuroimaging. Radiol Case Rep. 2026 May; 21(5):2095-2100. Ibrahim O, Cho NS, Le VL, Sanvito F, Yao J, Teraishi A, Lai A, Nghiemphu PL, Salamon N, Rodriguez FJ, Everson R, Cloughesy TF, Ellingson BM. PMID: 41769184; PMCID: PMC12936475.
    View in: PubMed Mentions:
  2. Perfusion, diffusion, and anatomical MRI characteristics of pathologically confirmed malignant transformation in IDH-mutant gliomas. Neuro Oncol. 2025 Dec 01; 27(12):3306-3317. Cho NS, Le VL, Teraishi A, Liu V, Sanvito F, Telesca D, Nakajo M, Wang C, Oshima S, Eldred BSC, Yao J, Nghiemphu PL, Salamon N, Cloughesy TF, Lai A, Ellingson BM. PMID: 40888039; PMCID: PMC12916721.
    View in: PubMed Mentions: Fields:
  3. Impact of corticosteroid administration on contrast-enhancing volume and diffusion MRI in treatment naïve glioblastoma. Neuro Oncol. 2025 Nov 01; 27(11):3016-3026. Sanvito F, Kim A, Raymond C, Teraishi A, Everson RG, Nghiemphu PL, Lai A, Chong RA, Nathanson DA, Salamon N, Cloughesy TF, Yao J, Ellingson BM. PMID: 40443040; PMCID: PMC12908483.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  4. Interplay Between Sex and Cytosine-Adenine-Guanine-Age Product Score in Huntington's Disease: Clinical and Neuroimaging Perspectives. Mov Disord. 2026 Feb; 41(2):489-499. Yao J, Feng G, Shao G, Wang Z, Mendizabal A, Telesca D, Fang K, Ibragimova L, Shoaib J, Morrison MA, Lupo JM. PMID: 40985165; PMCID: PMC12951279.
    View in: PubMed Mentions: Fields:
  5. Diffusion and contrast-enhancement MRI phenotypes associated with immune checkpoint inhibitor exposure and with immune cell infiltration in brain metastases. Neuro Oncol. 2025 Sep 17; 27(8):2194-2205. Sanvito F, Nocera G, Wang Z, Shiuan E, Sun L, Oshima S, Kim A, Kryukov I, Shao G, Cho NS, Salamon N, Ellingson BM, Prins R, Kim W, Yao J. PMID: 40119850; PMCID: PMC12448849.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  6. Along-Tract Diffusion Alterations in the Dentato-Rubro-Thalamic Tract Correlate With Motor and Cognitive Decline in Huntington's Disease. Hum Brain Mapp. 2025 Aug 01; 46(11):e70305. Wang Z, Solomon A, Lupo JM, Yao J. PMID: 40748199; PMCID: PMC12315238.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  7. Independent histological validation of MR-derived radio-pathomic maps of tumor cell density using image-guided biopsies in human brain tumors. J Neurooncol. 2025 Oct; 175(1):111-122. Nocera G, Sanvito F, Yao J, Oshima S, Bobholz SA, Teraishi A, Raymond C, Patel K, Everson RG, Liau LM, Connelly J, Castellano A, Mortini P, Salamon N, Cloughesy TF, LaViolette PS, Ellingson BM. PMID: 40542949; PMCID: PMC12367939.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  8. Super-resolution sodium MRI of human gliomas at 3T using physics-based generative artificial intelligence. J Neurooncol. 2025 Sep; 174(3):653-665. Raymond C, Yao J, Lopez Kolkovsky AL, Feiweier T, Clifford B, Meyer H, Zhong X, Han F, Cho NS, Sanvito F, Oshima S, Salamon N, Liau LM, Patel KS, Everson RG, Cloughesy TF, Ellingson BM. PMID: 40459830; PMCID: PMC12263758.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  9. Volumetric and diffusion MRI longitudinal patterns in brain metastases after laser interstitial thermal therapy. Eur Radiol. 2025 Oct; 35(10):5981-5993. Sanvito F, Yao J, Nocera G, Shao G, Wang Z, Cho NS, Teraishi A, Raymond C, Patel K, Pouratian N, Everson RG, Yang I, Salamon N, Kim W, Ellingson BM. PMID: 40251440; PMCID: PMC12417287.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  10. Advanced imaging characterization of post-chemoradiation glioblastoma stratified by diffusion MRI phenotypes known to predict favorable anti-VEGF response. J Neurooncol. 2025 Jul; 173(3):583-594. Sanvito F, Kryukov I, Yao J, Teraishi A, Raymond C, Gao J, Miller C, Nghiemphu PL, Lai A, Liau LM, Patel K, Everson RG, Eldred BSC, Prins RM, Nathanson DA, Salamon N, Cloughesy TF, Ellingson BM. PMID: 40227555; PMCID: PMC12170782.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  11. Leveraging Physics-Based Synthetic MR Images and Deep Transfer Learning for Artifact Reduction in Echo-Planar Imaging. AJNR Am J Neuroradiol. 2025 Apr 02; 46(4):733-741. Raymond C, Yao J, Clifford B, Feiweier T, Oshima S, Telesca D, Zhong X, Meyer H, Everson RG, Salamon N, Cloughesy TF, Ellingson BM. PMID: 39947682; PMCID: PMC11979845.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  12. Normalization of the percentage of signal recovery derived from dynamic susceptibility contrast perfusion MRI in brain tumors. Neuroradiology. 2025 Jun; 67(6):1405-1410. Sanvito F, Yao J, Cho NS, Telesca D, Salamon N, Cloughesy TF, Ellingson BM. PMID: 40067460; PMCID: PMC12357792.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  13. Multinuclear Interleaving of 1H CEST, Water T2*, and 23Na MRI at 3 T. NMR Biomed. 2025 Mar; 38(3):e70003. Lopez Kolkovsky AL, Wang C, Yao J, Ellingson BM. PMID: 39948226; PMCID: PMC11825412.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  14. A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma. Neurooncol Adv. 2025 Jan-Dec; 7(1):vdaf022. Ellingson BM, Okobi Q, Chong R, Plawat R, Zhao E, Gafita A, Sonni I, Chun S, Filka E, Yao J, Telesca D, Li S, Li G, Lai A, Nghiemphu P, Czernin J, Nathanson DA, Cloughesy TF. PMID: 40051661; PMCID: PMC11883343.
    View in: PubMed Mentions: 1
  15. Predicting Post-Operative Side Effects in VIM MRgFUS Based on THalamus Optimized Multi Atlas Segmentation (THOMAS) on White-Matter-Nulled MRI: A Retrospective Study. AJNR Am J Neuroradiol. 2025 Feb 03; 46(2):330-340. Oshima S, Kim A, Sun XR, Rifi Z, Cross KA, Fu KA, Salamon N, Ellingson BM, Bari AA, Yao J. PMID: 39730158; PMCID: PMC11878955.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  16. "Synthetic" DSC Perfusion MRI with Adjustable Acquisition Parameters in Brain Tumors Using Dynamic Spin-and-Gradient-Echo Echoplanar Imaging. AJNR Am J Neuroradiol. 2025 Feb 03; 46(2):311-320. Sanvito F, Yao J, Cho NS, Raymond C, Telesca D, Pope WB, Everson RG, Salamon N, Boxerman JL, Cloughesy TF, Ellingson BM. PMID: 39242197; PMCID: PMC11878977.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  17. TRANSIENT ALTERATIONS IN THALAMO-CEREBELLAR FUNCTIONAL CONNECTIVITY IN PREMANIFEST HUNTINGTON'S DISEASE. medRxiv. 2025 Jan 15. Morrison MA, Yao J, Bhalerao R, Jakary A, Glueck J, Driscoll T, Geschwind MD, Nelson AB, Possin KL, Hess CP, Lupo JM. PMID: 39867412; PMCID: PMC11759595.
    View in: PubMed Mentions:
  18. Radio-pathomic estimates of cellular growth kinetics predict survival in recurrent glioblastoma. CNS Oncol. 2024 12 31; 13(1):2415285. Oshima S, Yao J, Bobholz S, Nagaraj R, Raymond C, Teraishi A, Guenther AM, Kim A, Sanvito F, Cho NS, Eldred BSC, Connelly JM, Nghiemphu PL, Lai A, Salamon N, Cloughesy TF, LaViolette PS, Ellingson BM. PMID: 39535237; PMCID: PMC11562955.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  19. Interplay between Sex and Disease Burden in Huntington's Disease: Clinical and Neuroimaging Perspectives. medRxiv. 2024 Nov 02. Yao J, Feng B S G, Shao M S G, Mendizabal A, Telesca D, Fang K, Ibragimova L, Shoaib J, Morrison MA, Lupo JM. PMID: 39574844; PMCID: PMC11581089.
    View in: PubMed Mentions:
  20. Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas. Neuroradiology. 2024 Dec; 66(12):2153-2162. Cho NS, Sanvito F, Le VL, Oshima S, Teraishi A, Yao J, Telesca D, Raymond C, Pope WB, Nghiemphu PL, Lai A, Salamon N, Cloughesy TF, Ellingson BM. PMID: 39377927; PMCID: PMC11611930.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  21. Digital "flipbooks" for enhanced visual assessment of simple and complex brain tumors. Neuro Oncol. 2024 Oct 03; 26(10):1823-1836. Cho NS, Le VL, Sanvito F, Oshima S, Harper J, Chun S, Raymond C, Lai A, Nghiemphu PL, Yao J, Everson R, Salamon N, Cloughesy TF, Ellingson BM. PMID: 38808755; PMCID: PMC11449060.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  22. Pseudo-Resting-State Functional MRI Derived from Dynamic Susceptibility Contrast Perfusion MRI Can Predict Cognitive Impairment in Glioma. AJNR Am J Neuroradiol. 2024 Oct 03; 45(10):1552-1561. Cho NS, Wang C, Van Dyk K, Sanvito F, Oshima S, Yao J, Lai A, Salamon N, Cloughesy TF, Nghiemphu PL, Ellingson BM. PMID: 38719607; PMCID: PMC11448991.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  23. Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction. AJNR Am J Neuroradiol. 2024 02 07; 45(2):188-197. Cho NS, Sanvito F, Le VL, Oshima S, Teraishi A, Yao J, Telesca D, Raymond C, Pope WB, Nghiemphu PL, Lai A, Cloughesy TF, Salamon N, Ellingson BM. PMID: 38238098; PMCID: PMC11285991.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  24. Quantification of the in vivo brain ultrashort-T2* component in healthy volunteers. Magn Reson Med. 2024 Jun; 91(6):2417-2430. Deveshwar N, Yao J, Han M, Dwork N, Shen X, Ljungberg E, Caverzasi E, Cao P, Henry R, Green A, Larson PEZ. PMID: 38291598; PMCID: PMC11076235.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  25. Altered Iron and Microstructure in Huntington's Disease Subcortical Nuclei: Insight From 7T MRI. J Magn Reson Imaging. 2024 Oct; 60(4):1484-1499. Yao J, Morrison MA, Jakary A, Avadiappan S, Rowley P, Glueck J, Driscoll T, Geschwind MD, Nelson AB, Possin KL, Xu D, Hess CP, Lupo JM. PMID: 38206986; PMCID: PMC11521114.
    View in: PubMed Mentions: 6 Fields:
    Translation:Humans
  26. pH-Weighted amine chemical exchange saturation transfer echo planar imaging visualizes infiltrating glioblastoma cells. Neuro Oncol. 2024 01 05; 26(1):115-126. Patel KS, Yao J, Cho NS, Sanvito F, Tessema K, Alvarado A, Dudley L, Rodriguez F, Everson R, Cloughesy TF, Salamon N, Liau LM, Kornblum HI, Ellingson BM. PMID: 37591790; PMCID: PMC10768991.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  27. Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRI. Eur Radiol. 2024 May; 34(5):3087-3101. Sanvito F, Raymond C, Cho NS, Yao J, Hagiwara A, Orpilla J, Liau LM, Everson RG, Nghiemphu PL, Lai A, Prins R, Salamon N, Cloughesy TF, Ellingson BM. PMID: 37882836; PMCID: PMC11045669.
    View in: PubMed Mentions: 10 Fields:
    Translation:Humans
  28. Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma. J Neurooncol. 2023 Oct; 165(1):101-112. Strowd R, Ellingson B, Raymond C, Yao J, Wen PY, Ahluwalia M, Piotrowski A, Desai A, Clarke JL, Lieberman FS, Desideri S, Nabors LB, Ye X, Grossman S. PMID: 37864646; PMCID: PMC10863646.
    View in: PubMed Mentions: 24 Fields:
    Translation:HumansCTClinical Trials
  29. Editorial for "Relationship Between Microstructural Alterations and Cognitive Decline After Whole-Brain Radiation Therapy for Brain Metastases: An Exploratory Whole-Brain MR Analysis Based on Neurite Orientation Dispersion and Density Imaging". J Magn Reson Imaging. 2024 01; 59(1):253-254. Yao J, Morrison MA, Lupo JM. PMID: 37194681.
    View in: PubMed Mentions: Fields:
  30. Comparison of quantitative susceptibility mapping methods for iron-sensitive susceptibility imaging at 7T: An evaluation in healthy subjects and patients with Huntington's disease. Neuroimage. 2023 01; 265:119788. Yao J, Morrison MA, Jakary A, Avadiappan S, Chen Y, Luitjens J, Glueck J, Driscoll T, Geschwind MD, Nelson AB, Villanueva-Meyer JE, Hess CP, Lupo JM. PMID: 36476567; PMCID: PMC11588860.
    View in: PubMed Mentions: 6 Fields:
    Translation:Humans
  31. Low rank off-resonance correction for double half-echo k-space acquisitions. Magn Reson Imaging. 2022 12; 94:43-47. Bydder M, Ali F, Saucedo A, Ghodrati V, Samsonov A, Akhtari M, Wang C, Hagiwara A, Yao J, Ellingson B. PMID: 36113740.
    View in: PubMed Mentions: 1 Fields:
  32. Amine-weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumors. NMR Biomed. 2023 06; 36(6):e4785. Cho NS, Hagiwara A, Yao J, Nathanson DA, Prins RM, Wang C, Raymond C, Desousa BR, Divakaruni A, Morrow DH, Nghiemphu PL, Lai A, Liau LM, Everson RG, Salamon N, Pope WB, Cloughesy TF, Ellingson BM. PMID: 35704275; PMCID: PMC13030910.
    View in: PubMed Mentions: 9 Fields:
    Translation:Humans
  33. Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors. Neuro Oncol. 2022 06 01; 24(6):1020-1028. Hagiwara A, Oughourlian TC, Cho NS, Schlossman J, Wang C, Yao J, Raymond C, Everson R, Patel K, Mareninov S, Rodriguez FJ, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Prins RM, Cloughesy TF, Ellingson BM. PMID: 34865129; PMCID: PMC9159421.
    View in: PubMed Mentions: 16 Fields:
    Translation:Humans
  34. Diagnostic and Prognostic Value of pH- and Oxygen-Sensitive Magnetic Resonance Imaging in Glioma: A Retrospective Study. Cancers (Basel). 2022 May 20; 14(10). Yao J, Hagiwara A, Oughourlian TC, Wang C, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 35626127; PMCID: PMC9139712.
    View in: PubMed Mentions: 4
  35. Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease. Front Oncol. 2022; 12:849993. Goldman J, Hagiwara A, Yao J, Raymond C, Ong C, Bakhti R, Kwon E, Farhat M, Torres C, Erickson LG, Curl BJ, Lee M, Pope WB, Salamon N, Nghiemphu PL, Ji M, Eldred BS, Liau LM, Lai A, Cloughesy TF, Chung C, Ellingson BM. PMID: 35371980; PMCID: PMC8964348.
    View in: PubMed Mentions: 3
  36. Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI. Sci Rep. 2022 01 20; 12(1):1078. Hagiwara A, Tatekawa H, Yao J, Raymond C, Everson R, Patel K, Mareninov S, Yong WH, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 35058510; PMCID: PMC8776874.
    View in: PubMed Mentions: 13 Fields:
    Translation:Humans
  37. "Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging. Neuroimage Clin. 2021; 32:102882. Hagiwara A, Yao J, Raymond C, Cho NS, Everson R, Patel K, Morrow DH, Desousa BR, Mareninov S, Chun S, Nathanson DA, Yong WH, Andrei G, Divakaruni AS, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 34911188; PMCID: PMC8609049.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  38. Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging. Sci Rep. 2021 07 22; 11(1):15011. Akbari H, Kazerooni AF, Ware JB, Mamourian E, Anderson H, Guiry S, Sako C, Raymond C, Yao J, Brem S, O'Rourke DM, Desai AS, Bagley SJ, Ellingson BM, Davatzikos C, Nabavizadeh A. PMID: 34294864; PMCID: PMC8298590.
    View in: PubMed Mentions: 14 Fields:
    Translation:HumansAnimals
  39. A study of 3D radial density adapted trajectories for sodium imaging. Magn Reson Imaging. 2021 11; 83:89-95. Bydder M, Ali F, Saucedo A, Hagiwara A, Wang C, Pham AD, Yao J, Ellingson BM. PMID: 34271088.
    View in: PubMed Mentions: 1 Fields:
  40. Preferential tumor localization in relation to 18F-FDOPA uptake for lower-grade gliomas. J Neurooncol. 2021 May; 152(3):573-582. Tatekawa H, Uetani H, Hagiwara A, Yao J, Yao J, Oughourlian TC, Ueda I, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Bahri S, Pope WB, Salamon N, Ellingson BM. PMID: 33704629; PMCID: PMC8221401.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  41. Detection of cerebral reorganization associated with degenerative cervical myelopathy using diffusion spectral imaging (DSI). J Clin Neurosci. 2021 Apr; 86:164-173. Wang C, Holly LT, Oughourlian T, Yao J, Raymond C, Salamon N, Ellingson BM. PMID: 33775321; PMCID: PMC8007933.
    View in: PubMed Mentions: 7 Fields:
    Translation:Humans
  42. A physical phantom for amine chemical exchange saturation transfer (CEST) MRI. MAGMA. 2021 Aug; 34(4):569-580. Yao J, Yao J, Wang C, Raymond C, Bergstrom B, Chen X, Das K, Dinh H, Kim ZS, Le AN, Lim MWJ, Pham JAN, Prusan JD, Rao SS, Nathanson DA, Ellingson BM. PMID: 33484366; PMCID: PMC12977180.
    View in: PubMed Mentions: 2 Fields:
  43. Minimizing echo and repetition times in magnetic resonance imaging using a double half-echo k-space acquisition and low-rank reconstruction. NMR Biomed. 2021 04; 34(4):e4458. Bydder M, Ali F, Ghodrati V, Hu P, Yao J, Ellingson BM. PMID: 33300182; PMCID: PMC7935763.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  44. Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study. Clin Nucl Med. 2020 Dec; 45(12):e505-e511. Tatekawa H, Yao J, Oughourlian TC, Hagiwara A, Wang C, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Salamon N, Ellingson BM. PMID: 33031233; PMCID: PMC7950323.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  45. Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomas. Neuroradiology. 2021 Jun; 63(6):857-868. Oughourlian TC, Yao J, Yao J, Hagiwara A, Nathanson DA, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 33106922; PMCID: PMC8071834.
    View in: PubMed Mentions: 7 Fields:
    Translation:Humans
  46. Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden. Neurosurgery. 2020 10 15; 87(5):931-938. Patel KS, Everson RG, Yao J, Yao J, Raymond C, Goldman J, Schlossman J, Tsung J, Tan C, Pope WB, Ji MS, Nguyen NT, Lai A, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 32365185; PMCID: PMC7566341.
    View in: PubMed Mentions: 15 Fields:
    Translation:Humans
  47. Influence of phosphate concentration on amine, amide, and hydroxyl CEST contrast. Magn Reson Med. 2021 02; 85(2):1062-1078. Yao J, Yao J, Wang C, Ellingson BM. PMID: 32936483; PMCID: PMC8258865.
    View in: PubMed Mentions: 1 Fields:
  48. Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas. J Neurooncol. 2020 Sep; 149(2):337-346. Tatekawa H, Hagiwara A, Uetani H, Yao J, Yao J, Oughourlian TC, Bahri S, Wang C, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. PMID: 32929644; PMCID: PMC7682113.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  49. Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma. Sci Rep. 2020 09 09; 10(1):14819. Patel KS, Yao J, Yao J, Raymond C, Yong W, Everson R, Liau LM, Nathanson D, Kornblum H, Wang C, Oughourlian T, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF, Ellingson BM. PMID: 32908231; PMCID: PMC7481206.
    View in: PubMed Mentions: 16 Fields:
    Translation:HumansAnimals
  50. Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study. Sci Rep. 2020 07 17; 10(1):11922. Yao J, Yao J, Hagiwara A, Raymond C, Shabani S, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 32681084; PMCID: PMC7367867.
    View in: PubMed Mentions: 24 Fields:
    Translation:HumansCells
  51. Voxelwise and Patientwise Correlation of 18F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes. J Nucl Med. 2021 03; 62(3):319-325. Tatekawa H, Hagiwara A, Yao J, Yao J, Oughourlian TC, Ueda I, Uetani H, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. PMID: 32646876; PMCID: PMC8049346.
    View in: PubMed Mentions: 10 Fields:
    Translation:HumansCells
  52. Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade Glioma. Clin Cancer Res. 2020 07 01; 26(13):3135-3144. Ellingson BM, Yao J, Yao J, Raymond C, Nathanson DA, Chakhoyan A, Simpson J, Garner JS, Olivero AG, Mueller LU, Rodon J, Gerstner E, Cloughesy TF, Wen PY. PMID: 32269051; PMCID: PMC8204664.
    View in: PubMed Mentions: 7 Fields:
    Translation:HumansCTClinical Trials
  53. Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas. J Neurooncol. 2020 Mar; 147(1):135-145. Oughourlian TC, Yao J, Yao J, Schlossman J, Raymond C, Ji M, Tatekawa H, Salamon N, Pope WB, Czernin J, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. PMID: 31981013; PMCID: PMC7080591.
    View in: PubMed Mentions: 8 Fields:
    Translation:Humans
  54. Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI. Neuro Oncol. 2019 09 06; 21(9):1184-1196. Yao J, Yao J, Chakhoyan A, Nathanson DA, Yong WH, Salamon N, Raymond C, Mareninov S, Lai A, Nghiemphu PL, Prins RM, Pope WB, Everson RG, Liau LM, Cloughesy TF, Ellingson BM. PMID: 31066901; PMCID: PMC7594567.
    View in: PubMed Mentions: 31 Fields:
    Translation:HumansCells
  55. Probabilistic independent component analysis of dynamic susceptibility contrast perfusion MRI in metastatic brain tumors. Cancer Imaging. 2019 Mar 18; 19(1):14. Chakhoyan A, Raymond C, Chen J, Goldman J, Yao J, Yao J, Kaprealian TB, Pouratian N, Ellingson BM. PMID: 30885275; PMCID: PMC6423873.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  56. Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry. Sci Rep. 2019 02 26; 9(1):2846. Chakhoyan A, Yao J, Yao J, Leu K, Pope WB, Salamon N, Yong W, Lai A, Nghiemphu PL, Everson RG, Prins RM, Liau LM, Nathanson DA, Cloughesy TF, Ellingson BM. PMID: 30808879; PMCID: PMC6391482.
    View in: PubMed Mentions: 29 Fields:
    Translation:Humans
  57. pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma. J Neurooncol. 2019 May; 142(3):587-595. Yao J, Yao J, Tan CHP, Schlossman J, Chakhoyan A, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 30806888; PMCID: PMC6482078.
    View in: PubMed Mentions: 25 Fields:
    Translation:Humans
  58. pH-weighted molecular MRI in human traumatic brain injury (TBI) using amine proton chemical exchange saturation transfer echoplanar imaging (CEST EPI). Neuroimage Clin. 2019; 22:101736. Ellingson BM, Yao J, Yao J, Raymond C, Chakhoyan A, Khatibi K, Salamon N, Villablanca JP, Wanner I, Real CR, Laiwalla A, McArthur DL, Monti MM, Hovda DA, Vespa PM. PMID: 30826686; PMCID: PMC6396390.
    View in: PubMed Mentions: 13 Fields:
    Translation:Humans
  59. Improving B0 Correction for pH-Weighted Amine Proton Chemical Exchange Saturation Transfer (CEST) Imaging by Use of k-Means Clustering and Lorentzian Estimation. Tomography. 2018 Sep; 4(3):123-137. Yao J, Yao J, Ruan D, Raymond C, Liau LM, Salamon N, Pope WB, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. PMID: 30320212; PMCID: PMC6173788.
    View in: PubMed Mentions: 19 Fields:
  60. 18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study. J Neurooncol. 2018 Sep; 139(2):399-409. Patel CB, Fazzari E, Chakhoyan A, Yao J, Yao J, Raymond C, Nguyen H, Manoukian J, Nguyen N, Pope W, Cloughesy TF, Nghiemphu PL, Czernin J, Lai A, Ellingson BM. PMID: 29679199; PMCID: PMC6092195.
    View in: PubMed Mentions: 27 Fields:
    Translation:Humans
  61. Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI). Magn Reson Med. 2018 11; 80(5):1962-1978. Harris RJ, Yao J, Yao J, Chakhoyan A, Raymond C, Leu K, Liau LM, Nghiemphu PL, Lai A, Salamon N, Pope WB, Cloughesy TF, Ellingson BM. PMID: 29626359; PMCID: PMC6107417.
    View in: PubMed Mentions: 25 Fields:
    Translation:Humans
  62. Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme. Curr Pharm Des. 2015; 21(36):5256-66. Yao J, Yao J, Hsu CH, Li Z, Kim TS, Hwang LP, Lin YC, Lin YY. PMID: 26412354.
    View in: PubMed Mentions: 13 Fields:
    Translation:HumansAnimals

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs